Celldex Therapeutics【CLDX】株式ニュース

名称	銘柄コード	市場	種別
Celldex Therapeutics Inc	CLDX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.32	-0.95%	33.30	06:30:00

始値	安値	高値	終値	前日終値
33.95	32.91	34.26	33.30	33.62

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/31	07:05	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/31	07:01	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/31	06:47	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/31	04:20	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/15	21:01	GLOBE	Celldex Announces First Patient Dosed in Phase 2 Study of..
2024/5/07	05:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	05:01	EDGAR2	Form 8-K - Current report
2024/5/07	05:01	GLOBE	Celldex Reports First Quarter 2024 Financial Results and..
2024/4/17	21:01	GLOBE	Celldex Announces Completion of Enrollment in Phase 2 Study..
2024/3/08	21:00	GLOBE	Celldex Therapeutics to Participate in the Leerink Partners..
2024/3/06	00:30	GLOBE	Celldex Therapeutics to Present at TD Cowen’s 44th Annual..
2024/3/06	00:10	GLOBE	Celldex Therapeutics Announces Closing of Public Offering of..
2024/3/02	06:10	EDGAR2	Form 8-K - Current report
2024/3/02	06:09	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/01	11:14	GLOBE	Celldex Therapeutics Announces Pricing of Upsized $400..
2024/2/29	06:10	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/29	06:01	GLOBE	Celldex Therapeutics Announces Proposed Public Offering of..
2024/2/26	22:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/26	21:05	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/26	21:01	EDGAR2	Form 8-K - Current report
2024/2/26	21:01	GLOBE	Celldex Reports Fourth Quarter and Year End 2023 Financial..
2024/2/25	04:05	GLOBE	Celldex Therapeutics Presents Positive 12 Week Results from..
2024/2/16	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/15	06:17	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	02:52	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/15	01:48	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/14	21:38	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/13	23:41	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/09	00:11	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/07	06:01	GLOBE	Celldex to Participate in the Guggenheim Healthcare Talks..
2024/2/05	22:01	GLOBE	Celldex Announces Upcoming Presentation of Barzolvolimab..
2024/1/05	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/28	06:15	GLOBE	Celldex Therapeutics to Present at 6th Annual Evercore ISI..
2023/11/21	06:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2023/11/09	07:03	EDGAR2	Form 8-K - Current report
2023/11/09	07:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/08	13:15	GLOBE	Celldex Therapeutics Announces Pricing of Public Offering of..
2023/11/08	06:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/08	06:01	GLOBE	Celldex Therapeutics Announces Proposed Public Offering of..
2023/11/06	23:00	EDGAR2	Form 8-K - Current report
2023/11/06	20:30	GLOBE	Celldex Therapeutics Announces Positive Topline Results from..
2023/11/06	05:00	GLOBE	Celldex Therapeutics Presents Positive Data from Prurigo..
2023/11/04	05:01	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2023/11/03	05:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03	05:01	EDGAR2	Form 8-K - Current report
2023/11/03	05:01	GLOBE	Celldex Reports Third Quarter 2023 Financial Results and..
2023/9/26	20:01	GLOBE	Celldex Announces Acceptance of Abstract for Barzolvolimab..
2023/9/25	21:31	GLOBE	Celldex Therapeutics to Present at Cantor Global Healthcare..
2023/8/09	05:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/09	05:01	EDGAR2	Form 8-K - Current report